NCT04204265View on ClinicalTrials.gov

MONOVISC for Shoulder Joint Pain Relief Due to Osteoarthritis

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

December 17, 2019

Primary Completion Date

February 26, 2021

Study Completion Date

March 30, 2021

Conditions
Osteo Arthritis Shoulders
Interventions
DEVICE

Monovisc

A chemically cross-linked sodium hyaluronate supplied as a 4 mL unit dose in a 5 mL glass syringe.

Trial Locations (4)

Unknown

Krajská zdravotní, a.s., Ústí nad Labem

Nzoz Medi-Spatz, Gliwice

SPORTO, Lodz

Przychodnia Rodzinna na Sadowej, Torun

Sponsors
All Listed Sponsors
lead

Anika Therapeutics, Inc.

INDUSTRY